Dissecting the mechanisms behind chronic inflammation

Dissecting the mechanisms behind chronic inflammation
Credit: Thinkstock

European scientists joined forces to unravel how a physiological process such as inflammation can turn pathological. Project findings have the potential to provide answers to many inflammatory disorders.

Upon infection or injury, are attracted to the site through the , a process known as inflammation. Although this is considered normal, prolonged activation of this process leads to the pathological state of chronic inflammation. It is becoming increasingly evident that chronic inflammation is the leading cause of many diseases including .

To achieve a thorough understanding of directed inflammatory cell migration towards and across injured tissues, the EU-funded ‘Targeting cell migration in chronmic inflammation’ (MAIN) project brought together over 48 leading research teams in the field.

The MAIN project was divided into tightly interconnected research programmes of highly integrated activities. Some groups were involved in the Tool Development Programme (TDP) which dealt with the development of technological tools including imaging and RNAi interference for studying cell migration. Identification of signalling pathways and molecular networks that regulate inflammatory cell migration was part of the Target Identification Program (TIP) and provided cues to underlying mechanisms of chronic inflammation.

At the same time, potential targets were tested in the Target Validation Program (TVP) using in vitro and in vivo models while novel assays were generated under the project’s Drug Development Program (DDP).

Collectively, the information generated during the MAIN project provided significant basic knowledge on what determines inflammatory and how this goes wrong during chronic inflammation. This information could be exploited for the future design of drugs against .

add to favorites email to friend print save as pdf

Related Stories

Gatekeeper signal controls skin inflammation

Jan 26, 2012

A new study unravels key signals that regulate protective and sometimes pathological inflammation of the skin. The research, published online on January 26th in the journal Immunity by Cell Press, identifies a "gatekeeper" that, ...

First step to new therapy for chronic bowel disease

Jul 06, 2010

Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University (UGent) have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. ...

Recommended for you

A better biomonitor for children with asthma

Dec 10, 2014

For the firefighters and rescue workers conducting the rescue and cleanup operations at Ground Zero from September 2001 to May 2002, exposure to hazardous airborne particles led to a disturbing "WTC cough"—obstructed ...

New insight into risk of Ankylosing Spondylitis

Dec 09, 2014

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

Novel approach to treating asthma: Neutralize the trigger

Dec 03, 2014

Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by millions of Americans every year, but they don't get to the root cause of the condition. Now, for the first time, scientists ...

Inflammatory discovery sheds new light on skin disease

Dec 02, 2014

Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.